Intervacc is trading at €0.07, up 7.85%, with the reason for the move unclear.
- No reliable report or September 30 announcement identified a specific catalyst for the gain.
- Intervacc had previously announced its CEO would participate in the Swiss Nordic Bio Conference on October 1; the announcement does not establish a connection to the share-price increase. The supplied market context shows no significant move in major indices that would explain the gain.